Is My Nose Bleeding? I Just Got “Einhorned”: CIGNA Corporation (CI), Ventas, Inc. (VTR), Herbalife Ltd. (HLF)

Page 1 of 2

“I could tell that my parents hated me. My bath toys were a toaster and a radio.” – Rodney Dangerfield

My name will never be used as a verb. First off, it’s much too difficult for most people to even attempt to pronounce. Looking at it, do you Americanize it? Do you go old school French-Canadian? What’s the proper tense? I’m at peace with it. Believe me, it’s quite alright.

October of last year, Greenlight Capital President and founder, David Einhorn presented his stock findings with a slick, well thought out PowerPoint display, cool music, but no fog machines. The Wall Street wizard offered some light fare prior to naming names, even joking about his own being utilized as a verb when referencing certain stocks. “Herbalife Ltd. (NYSE:HLF) got Einhorned,” which actually sounds like it could leave a nasty scar, what with the “horn” delicately placed within his surname.

Herbalife Ltd. (NYSE:HLF)One of the stock mentions I found rather interesting from the Fonz of hedge fund managers, was CIGNA Corporation (NYSE:CI), which probably covered most of those who signed the Declaration of Independence.  To be unflinchingly honest, I never gave the company a second look until it was mentioned rather favorably by Einhorn. In light of the Supreme Court upholding the Affordable Care Act, everyone had some opinion on the healthcare sector, even yours truly.

I mentioned Ventas, Inc. (NYSE:VTR), prior to Einhorn’s stock laser show, and being a meat-eating, red-blooded, all-American male; I thought it would be a rather fun endeavor to embark on my own little fantasy stock steel cage match, since the timing was so fresh with our mentions. Also being a man of my word, I announced to my faithful following (all 15 of you), that I would keep everyone posted on this most public, potentially embarrassing stage, our own unforgiving Internet. Following a respectable showing in 2012 (up 16%), Ventas is already steadily moving ahead year-to-date, up about 2%. About a dollar under their 52-week high ($54-$68), I think the performance will continue the slow grind upward this year and beyond, breaking through the $68 ceiling a few times along the way. As I mentioned when I accepted my own challenge, Ventas clobbers Cigna when it comes to the trusty dividend, doling out 62-cents per share each quarter ($2.48 annually), for a healthy 3.7% yield. Compared to Cigna’s anemic, 0.1% dividend yield, paid in the form of 4 shiny pennies once a year for each loyally held share of stock, Ventas wins that battle.

Cigna had a very nice run in 2012, with the stock picking up over 23% in gains (almost 20% since Einhorn’s mention, though), and currently rides that momentum into 2013, up over 6% year-to-date. The company is nipping at the heels of their 52-week high ($39-$59), and will most likely pierce that number this year, but I expect it to gradually slow down, especially if Einhorn looks elsewhere for more substantial gains.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!